Abstract

ABSTRACT Background and Objectives: The aim of this study is to investigate the application of three-dimensional (3D) visualization technique in the surgical treatment of malignant tumors of the hilar and common bile ducts. Materials and Methods: A total of 23 patients admitted from January 2015 to April 2017 for surgical treatment were analyzed, of whom 13 patients underwent medical image 3D visualization system (treatment group) while 10 underwent surgery alone (control group). Indicators to the treatment effects were recorded and compared between the two groups, including the operation time, intraoperative bleeding volume, postoperative hospitalization time, the number of dissected lymph nodes, the incidence of all postoperative complications, and the alanine transaminase (ALT), albumin (ALB), and total bilirubin (TBIL) monitored on days 1, 3, 5, and 7 after the operation. Results: In the treatment group and control group, the operation time was 194.66 ± 13.79 and 230.81 ± 27.07 min (t = 3.857, P = 0.002), the intraoperative bleeding volume was 274.28 ± 44.57 and 320.69 ± 35.90 mL (t = 2.686, P = 0.014), the postoperative hospitalization time was 11.15 ± 1.25 and 15.25 ± 1.75d (t = 6.557, P = 0.000), the number of dissected lymph nodes 10.46 ± 1.71 and 7.40 ± 0.97 (t = 5.050, P = 0.000), and the incidence of all postoperative complications 7.69% and 60% (χ2 = 7.304, P = 0.019), respectively. The level of ALT and TBIL was significantly higher in the treatment group than in the control group, whereas the level of ALB was significantly lower in the treatment group than in the control group on days 3, 5, and 7 (P < 0.05). The recovery of liver function was better in the treatment group than in the control group. In addition, no perioperative deaths were found in either group. Conclusions: In the surgical treatment of malignant tumors occurring in the hilar to the common bile duct, 3D visualization technology can reduce the operation injury and intraoperative bleeding, decrease the incidence of postoperative complications, improve the safety and effectiveness of the operation, and promote the recovery of liver function, thus demonstrating promising short-term efficacy.

Full Text
Paper version not known

Talk to us

Join us for a 30 min session where you can share your feedback and ask us any queries you have

Schedule a call

Disclaimer: All third-party content on this website/platform is and will remain the property of their respective owners and is provided on "as is" basis without any warranties, express or implied. Use of third-party content does not indicate any affiliation, sponsorship with or endorsement by them. Any references to third-party content is to identify the corresponding services and shall be considered fair use under The CopyrightLaw.